An Integrated Algorithm with Feature Selection, Data Augmentation, and XGBoost for Ovarian Cancer

Ovarian cancer is one of the most aggressive gynecological cancers due to its high invasion and chemoresistance. It not only has a high incidence rate but also tops the list of mortality rates. Its subtle early symptoms make subsequent diagnosis difficult, significantly delaying timely treatment for patients. Once ovarian cancer reaches an advanced stage, the complexity and difficulty of treatment increase substantially, affecting patient survival rates. Therefore, it is crucial for both medical professionals and patients to remain highly vigilant about the early signs of ovarian cancer to ensure timely intervention. In recent years, ovarian cancer prediction research has advanced, allowing for the analysis of the likelihood and type of cancer based on patients’ genetic data. With the rapid development of machine learning, numerous efficient classification prediction models have emerged. These new technologies offer significant opportunities and potential for developing ovarian cancer diagnostic prediction methods. However, traditional approaches often struggle to achieve satisfactory classification accuracy in high-dimensional genetic datasets with small sample sizes. This research offers a prediction model utilizing genomic data to enhance the early diagnosis rate of ovarian cancer, incorporating feature selection, data augmentation through adversarial conditional generative adversarial networks (AC-GAN), and an extreme gradient boosting (XGBoost) classifier. First, we can simplify the original genetic dataset through feature selection methods, removing irrelevant variables and noise, thereby improving the model’s predictive accuracy. Following dimensionality reduction, AC-GAN enriches the data, producing more realistic genetic samples to enhance the model’s generalization capacity. Finally, the XGBoost classifier is applied to classify the augmented data, achieving efficient predictions for ovarian cancer. These research findings strongly demonstrate that the diagnostic method proposed in this paper has a significant advantage in the predictive diagnosis of ovarian cancer, with an accuracy of 99.01% that surpasses the current technologies in use. Additionally, the algorithm identifies twelve genes highly relevant to ovarian cancer, providing valuable insights for physicians during diagnosis.